- About the Center
- Research Programs
- Addiction Genetics and Pharmacogenetics Division
- Addiction Treatment and Medication Development Division
- The Penn PET Addiction Center of Excellence (PACE)
- Molecular Imaging and Neuroimaging Division (MIND-CSA)
- Clinical Trials Network
- Continuing Care and Assessment Division
- Integrated Care for Primary Care
- Clinical Trial Participation
- Treatment Options
- Affiliated Divisions
- Center Faculty
- Post Doctoral Fellowships
- Recorded Seminars
- Contact Us
- Support Our Work
Training Program Overview
There are three fellowship programs for individuals interested in addictions treatment or research. These include a one-year clinical fellowship that leads to eligibility for board certification in Addiction Psychiatry. A second fellowship is a two-year research and clinical training program that is offered through the Mental Illness, Research, Education and Clinical Center at the Philadelphia VAMC. Third is a NIDA institutional research training grant (T32) that supports two years of training for pre-doctoral and post-doctoral candidates. NIDA fellows can select a basic science emphasis and work with faculty in behavioral pharmacology, genetics, molecular biology or neuroscience or a clinical focus that includes training in research methodology, diagnosis and treatment, neuroimaging, genetics, and pharmacogenetics. The CSA recruits jointly for these three programs.
Purpose/Areas of Focus
The Center for Studies of Addiction (CSA) in the Department of Psychiatry offers post-graduate basic science and clinical research training programs focusing on a wide range of substance abuse, including nicotine, alcohol, cocaine, and heroin use disorders. The pre-clinical program emphasizes animal models of addiction, epigenetic transmission of addiction risk, and preclinical testing of potential therapeutic drugs. The clinical programs emphasize multimodal treatment, dual diagnosis, medications development through randomized clinical trials, and genetic and other moderators of treatment effects. Funding is provided by the National Institute on Drug Abuse (NIDA) for one research fellowship and by the Department of Veterans Affairs (VA) for two programs, one predominantly clinical and the other predominantly research.
Holders of MD or PhD degrees or other relevant doctoral degrees, and pre-doctoral trainees who are advanced graduate students in the Biomedical Graduate Studies program at the University of Pennsylvania are eligible to apply. The positions are open to citizens, non-citizen nationals, or permanent residents of the United States. The clinical training program at the Philadelphia VAMC is certified by the American Board of Medical Specialties. Thus, psychiatrists can qualify for board certification in Addiction Psychiatry.
Requirements for Addiction Psychiatry
For acceptance into the Addiction Psychiatry Fellowship Program at the University of Pennsylvania, applicants must have completed a General Psychiatry Residency, and are required to obtain an unrestricted medical training (MT) license prior to starting their clinical experience. In addition, all newly selected fellows must apply for and receive a Pennsylvania Training License, in order to lawfully practice in Pennsylvania. This particular Fellowship is funded through a disbursement agreement between the U.S. Department of Veterans Affairs and Penn. Only psychiatrists who are U.S. citizens or permanent residents of the U.S. are eligible.
Number of Positions
Currently there are 2 Addiction Psychiatry slots, 4 VA research training slots, with a variable ratio of MD and PhD fellows, and 8 NIDA slots for both pre-doctoral and post-doctoral trainees.
Back to Top